Astera Labs, Inc.
ALAB
$71.20
-$0.44-0.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 490.47M | 396.29M | 305.71M | 229.55M | 163.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 490.47M | 396.29M | 305.71M | 229.55M | 163.39M |
| Cost of Revenue | 118.88M | 93.59M | 68.43M | 52.05M | 37.30M |
| Gross Profit | 371.59M | 302.70M | 237.28M | 177.50M | 126.09M |
| SG&A Expenses | 181.58M | 217.94M | 180.51M | 143.85M | 107.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 512.29M | 512.36M | 412.90M | 329.82M | 256.93M |
| Operating Income | -21.81M | -116.07M | -107.19M | -100.27M | -93.54M |
| Income Before Tax | 20.35M | -81.78M | -81.79M | -84.06M | -86.03M |
| Income Tax Expenses | -21.04M | 1.64M | 12.02M | 5.29M | 15.77M |
| Earnings from Continuing Operations | 41.39 | -83.42 | -93.81 | -89.34 | -101.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.39M | -83.42M | -93.81M | -89.34M | -101.80M |
| EBIT | -21.81M | -116.07M | -107.19M | -100.27M | -93.54M |
| EBITDA | -18.15M | -112.91M | -104.47M | -97.92M | -91.50M |
| EPS Basic | 0.25 | -1.71 | -1.50 | -1.53 | -2.03 |
| Normalized Basic EPS | 0.08 | -0.96 | -0.83 | -0.84 | -1.06 |
| EPS Diluted | 0.22 | -1.73 | -1.50 | -1.53 | -2.03 |
| Normalized Diluted EPS | 0.07 | -0.97 | -0.83 | -0.84 | -1.06 |
| Average Basic Shares Outstanding | 635.12M | 524.46M | 403.21M | 283.84M | 165.21M |
| Average Diluted Shares Outstanding | 667.71M | 542.12M | 403.21M | 283.84M | 165.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |